Scientist II, Platform Biology

The Scientist II, Platform Biology reports to the Associate Director of Platform Biology and designs and executes experiments that underpin multiple aspects of regulatable systems that can be implemented across different therapeutic targets., This position will be located in our Edinburgh, UK site and will be a fixed term contract for one year.,

• Use molecular biology, protein and cell biology methods to lead, execute and support multiple projects within regulatable systems
• Conduct experiments and analyses as part of a variety of research and development activities, e.g., small-scale studies, scale up studies, technology transfer
• Actively participate as a member within multifunctional project teams, acting as a project lead in specific cases.
• Evaluate and summarize experimental data and present findings to the greater Askbio community
  
  PhD graduate with at least two years of post-PhD experience (either academic or industry)
• Experience in cell and protein biology and expertise in molecular biology
• Demonstrated ability to generate results and innovative solutions with minimum supervision
• Strong analytical and problem-solving skills
• Proficiency with MS Suite and ability to learn new software programs quickly
Preferred Education, Experience and Skills
• Self-motivated, organized, capable of working independently as well as in a collaborative/group environment
• Experience with viral and/or non-viral delivery platforms
• Strong oral and written communication skills
• Good judgment and innovation to achieve a solution within standard practices and procedures
  
  Asklepios BioPharmaceutical, Inc. (AskBio) is a leading, clinical-stage gene therapy company founded in 2001 based on the work of adeno-associated virus (AAV) gene therapy visionary and pioneer, Jude Samulski, PhD. Since that time, our commitment to developing life-saving medicines that can potentially cure genetic diseases has never wavered.
At AskBio, we've built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe disease, Parkinson's disease, and congestive heart failure. Our gene therapy platform includes Pro10 , an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid and promoter library. We became a wholly-owned, independently operated, subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy (CGT) platform. Our global headquarters is in Research Triangle Park, NC. Additionally, we have significant operations in Philadelphia, PA, Columbus, OH, Scotland, France, Germany, and Spain. Our vision: Pioneering science to create transformative molecular medicines. Our mission: Lead innovative science and drive clinical outcomes to transform people's lives. Our principles:
• Advance innovative science by pushing boundaries.
• Bring transformative therapeutics to patients in need.
• Provide an environment for employees to reach their fullest potential.
Our values:
• Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need.
• Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view.
• Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers.
• Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action.
• Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what's right in every situation. Make clear commitments and follow through.